Evidence map›Paper›PMID 20658326›Full record

ArticleIndian journal of gastroenterology : official journal of the Indian Society of Gastroenterology2010

Characterization of clarithromycin resistance in isolates of Helicobacter pylori from the UAE.

Mubarak S Alfaresi, Abida A Elkoush

Abstract read
PubMed Publisher
In one paragraph

Article in Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Prevalence of CagA and antimicrobial sensitivity ofInfectious agents and cancer · 2018
    Article
  6. Article
  7. Review
  8. Helicobacter pylori eradication in West Asia: a review.World journal of gastroenterology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mubarak S AlfaresiDepartment of Pathology and Laboratory Medicine, Zayed Military Hospital, Abu Dhabi, United Arab Emirates. uaenow@eim.ae
Abida A Elkoush

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClarithromycin therapy is effective in eradicating Helicobacter pylori. However, the resistance of H. pylori to clarithromycin is increasingly reported. The present study aimed to characterize the types of mutations present in the 23S rRNA genes of isolates of clarithromycin-resistant H. pylori from the UAE.

methodsClarithromycin susceptibility of H. pylori isolates (n = 26) was determined by E tests. Analyses for point mutations in domain V of the 23S rRNA genes in clarithromycin-resistant and-sensitive strains were performed by sequence analysis of amplified PCR products.

resultsOut of 100 gastric antral biopsy samples, 26 were positive for H. pylori by culture, and 29 were positive by PCR. Of the 26 culture isolates, five (19.2%) were resistant to clarithromycin and 24 were sensitive. The MIC of the resistant strains ranged from 3 to 24 microg/mL (median 24). All of the clarithromycin-resistant isolates had point mutations in the 23S rRNA gene. Two isolates had an A2142G 23S rRNA mutation, and three had A2143G mutations.

conclusionClarithromycin resistance was common in this small collection of H. pylori isolates from the UAE. The A2142G and A2143G mutations were associated with clarithromycin resistance.

Indexed as

Anti-Bacterial AgentsBase SequenceBiopsyClarithromycinDrug Resistance, BacterialGenes, rRNAHelicobacter InfectionsHelicobacter pyloriHumansMicrobial Sensitivity TestsPoint MutationPolymerase Chain ReactionRNA, Ribosomal, 23SSequence Analysis, DNAUnited Arab EmiratesAnti-Bacterial AgentsClarithromycinRNA, Ribosomal, 23S

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.